Regulatory T cells (T regs)
Introduction
Regulatory T cells (T regs ) actively mediate self-tolerance and thus control autoimmunity. 1,2 T regs also limit antitumor T-cell responses and deleterious allogeneic T-cell responses that cause graft-versushost disease (GVHD) 3, 4 and solid organ allograft rejection, 5 making them valuable therapeutic targets. We previously found that donor and host allogeneic responses are compromised in SH2 domaincontaining inositol 5-phosphatase (SHIP)-deficient hosts, which exhibit significantly reduced acute rejection of MHC-mismatched bone marrow grafts and GVHD. 6, 7 Thus, an immunosuppressive environment prevails in SHIP-deficient hosts. We consistently observe a profound expansion of myeloid suppressor cells (MySC) in SHIP-deficient mice. [6] [7] [8] [9] Because host and donor T regs limit GVHD 4, 10 and Mac1 ϩ Gr1 ϩ cells, similar to SHIP Ϫ/Ϫ MySC, expand T regs in tumor and GVHD models 11, 12 ; we considered that the T reg compartment in SHIP-deficient hosts may also be expanded. In addition, SHIP deficiency could intrinsically effect T reg homeostasis and function. SHIP can oppose PI3K signaling pathways triggered by engagement of costimulatory and cytokine receptors critical for the suppressive function, survival, and expansion of T regs , such as CD25 (interleukin-2 receptor ␣), IL-7R, and OX40. [13] [14] [15] Because T regs were initially characterized as CD4 ϩ T cells coexpressing CD25, most T reg studies focus on this phenotype, which is shared with activated CD4 ϩ T cells. 16 To distinguish between T regs and activated T cells, molecular markers correlated with or obligate for T reg function have been identified, such as the transcription factor FoxP3, as well as surface markers CD103, glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) and OX40, among others. FoxP3 functions as the master regulator in the development and suppressive ability of T regs . 17 CD103 expression among CD4 ϩ CD25 ϩ T regs distinguishes an effector/memory-like subset that displays an inflammationseeking phenotype and exhibits greater suppressive capacity. 18, 19 In addition, CD103, which binds E-cadherin, mediates the retention of CD103 ϩ lymphocyte in epithelial compartments, 19 which are major sites of GVHD. Thus, CD103 ϩ T regs might have a prominent role in the prevention against GVHD. GITR and OX40, members of the tumor necrosis factor receptor superfamily of receptors, are costimulatory molecules known to play key roles in promoting the homeostasis, expansion, and suppressive capability of T regs . 20, 21 Furthermore, CD4 ϩ CD25 ϩ OX40 ϩ T regs represent a mature population that does not require preactivation or stimulation to suppress antigen-specific T-cell responses. 22 Analysis of CD103, GITR, and FoxP3 expression has allowed the identification of a T reg population among "naive" CD4 ϩ CD25 Ϫ T cells. Specifically, CD4 ϩ CD25 Ϫ CD103 ϩ T cells display regulatory activity in both an in vitro proliferation assay and in vivo disease models, such as colitis and antigen-induced arthritis. 18, 23 Additionally, CD4 ϩ CD25 Ϫ GITR ϩ T cells express IL-10, TGF-␤, and intracellular CTLA-4, are anergic, suppress T-cell proliferation, and can prevent wasting disease, colitis, autoimmune myocarditis, diabetes, and multiorgan inflammation. 24, 25 Thus, when assessing the entire T reg compartment, one should also consider these immunoregulatory subsets within the "naive" CD4 ϩ CD25 Ϫ T-cell compartment.
Using 3 murine genetic models of SHIP deficiency, we show here that the frequency of CD4 ϩ CD25 ϩ FoxP3 ϩ T reg and CD4 ϩ CD25 Ϫ FoxP3 ϩ T cells is increased in SHIP-deficient mice. We find that the suppressive capacity of SHIP-deficient CD3 ϩ CD4 ϩ CD25 ϩ T regs (CD25 ϩ T regs ) is equal to that of wild-type (WT) CD25 ϩ T reg . Interestingly, the SHIP-deficient CD3 ϩ CD4 ϩ CD25 Ϫ T-cell (CD25 Ϫ T-cell) compartment displays significant immunosuppressive capacity in vitro and in vivo, possibly because of the increase in FoxP3 ϩ T cells. Furthermore, the surface expression of CD103, GITR, OX40, and Fc␥RII/III is significantly increased in SHIP-deficient CD25 Ϫ and CD25 ϩ CD4 ϩ T-cell compartments. These qualitative changes possibly increase the survival and immunosuppressive capacity of the SHIPdeficient T-cell compartment and contribute to the reduced host-versusgraft and graft-versus-host responses observed in SHIP-deficient hosts.
Methods

Mice
SHIP Ϫ/Ϫ mice were created previously in our laboratory 6 and maintained by intercrossing SHIP ϩ/Ϫ mice (F10 to the C57BL/6J background). The creation of SHIP ⌬IP/⌬IP mice is described in Karlsson et al. 26 SHIP-deficient mice and WT littermates used were between 6 and 9 weeks of age. Mice with germline transmission of a SHIP flox allele were previously created in our laboratory 6 and are maintained by intercrossing SHIP flox/flox mice (F10 to the C57BL/6J background). MxCre transgenic mice (The Jackson Laboratory, Bar Harbor, ME) were intercrossed with SHIP flox/flox mice to generate MxCreSHIP flox/flox on a C57BL/6J background. MxCreSHIP flox/flox and SHIP flox/flox littermates were generated by intercrossing MxCreSHIPflox/flox and SHIP flox/flox mice. Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ mice on an H2d background were obtained from Hergen Spits 27 (Netherlands Cancer Institute, Amsterdam, The Netherlands) and propagated in the Moffitt Stabile Vivarium. Severe combined immunodeficient (SCID) mice (C57BL/6J background) were purchased from The Jackson Laboratory. Studies were performed in accordance with the guidelines and approval of the Institutional Animal Certification and Use Committee at the University of South Florida.
Conditional deletion of SHIP
SHIP was conditionally deleted in MxCreSHIP flox/flox mice by intraperitoneal injection of 625 g polyinosinic-polycytidylic acid (polyI/C; SigmaAldrich, St Louis, MO) on days 0, 3, and 6 as described by Desponts et al. 28 
Cell purification
Whole splenocytes from SHIP Ϫ/Ϫ , SHIP ⌬IP/⌬IP , MxCreSHIP flox/flox , and respective littermate controls were magnetically enriched for CD3 ϩ T cells using anti-CD3-phycoerythrin (PE), Miltenyi anti-PE microbeads, and an Automacs (Miltenyi Biotec, Auburn, CA) per the manufacturer's instructions. The positive fraction was stained for CD8, CD4, CD25, and viability (4Ј,6-diamidino-2-phenylindole dihydrochloride [DAPI]), then sorted for CD3 ϩ CD4 ϩ CD25 Ϫ CD8 Ϫ and CD3 ϩ CD4 ϩ CD25 ϩ CD8 Ϫ T cells using a BD FACSAria cell sorter. Population purity was more than 95% as determined by postsort analysis. Sorted cells were used for Western blot analysis, in vitro mixed leukocyte reactions (MLRs), or adoptive transfer.
Flow cytometry
For phenotypic analysis of viable T cells, splenocytes, mesenteric lymph node (LN) cells, or thymocytes were Fc-blocked and stained using fluorescent-conjugated antibodies against the following surface markers: CD3, CD4, CD25, CD103, GITR, OX40, CD127, and CD16/32 (R&D Systems, Minneapolis, MN), along with 4,6-diamidino-2-phenylindole, a viability dye. For intracellular FoxP3 expression, cells were stained as mentioned above, then permeabilized and fixed using the eBioscience Fixation/Permeabilization kit (eBioscience, San Diego, CA), and stained with anti-FoxP3 (FJK-16a). All samples were analyzed on an LSRII (BD Biosciences, San Jose, CA). All antibodies except CD16/32 were purchased from BD Biosciences PharMingen (San Diego, CA) or eBioscience.
Western blotting
Fluorescence-activated cell sorter (FACS)-sorted CD3 ϩ CD4 ϩ CD25 Ϫ CD8 Ϫ and CD3 ϩ CD4 ϩ CD25 ϩ CD8 Ϫ T cells were lysed for 30 minutes on ice in a modified TNE buffer (50 mM Tris-HCl, 1% Nonidet P-40, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaOV, 1 mM NaF, and protease inhibitors). Equal cell equivalents were resolved on a 4% to 12% Bis-Tris gel (Invitrogen, Carlsbad, CA) and transferred to a Hybond-ECL nitrocellulose membrane (GE Healthcare, Little Chalfont, United Kingdom). Blots were blocked with Odyssey blocking buffer (LI-COR Biosciences, Lincoln, NE), probed with antibodies against SHIP1 (P1C1, 1:200) or FoxP3 (eBio7979, 1:500) and ␤-actin (C-11, 1:500) followed by a fluorochrome-tagged secondary. Probed blots were developed on a LI-COR Odyssey imager to quantitate and normalize SHIP levels or FoxP3 levels to ␤-actin, displayed as arbitrary fluorescence units (AFU). 
Mixed leukocyte reaction
CD4 ϩ CD25 ϩ CD8 Ϫ T regs , SHIP-deficient CD3 ϩ CD4 ϩ CD25 ϩ CD8 Ϫ T regs , or SHIP-deficient CD3 ϩ CD4 ϩ CD25 Ϫ CD8 Ϫ T
Adoptive transfer of T cells for colitis and GVHD induction
In the syngeneic colitis model, to assess T reg function, C57BL/6J SCID hosts received 4 ϫ 10 5 sorted CD3 ϩ CD4 ϩ CD25 Ϫ CD8 Ϫ T cells from WT C57BL/6J donors along with or without 7 ϫ 10 4 sorted CD3 ϩ CD4 ϩ CD25 ϩ CD8 Ϫ T regs from WT or SHIP Ϫ/Ϫ C57BL/6J donors by intraperitoneal injection on day 1. In parallel, a control group of C57BL/6J SCID hosts received a phosphate-buffered saline (PBS) injection. In the allogeneic GVHD colitis model, to assess allogeneic T-cell response, Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ mice (on an H2d background) received 10 5 sorted CD3 ϩ CD4 ϩ CD25 Ϫ CD8 Ϫ T cells from WT or SHIP Ϫ/Ϫ C57BL/6J donors by retro-orbital injection. In parallel, a control group of Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ mice hosts received a PBS injection.
Clinical and histologic examination of colitis
Recipient mice were weighed and monitored for colitis-associated appearance 3 times per week. Recipient mice were kept in a pathogen-free barrier room for 8 to 12 weeks after cell transfer. When premoribund (lost Ն 10% or more of its starting body weight) or after 8 to 12 weeks after cell transfer, recipient mice were killed and given a disease activity index (DAI). The colon was obtained from each mouse and fixed in 10% phosphate-buffered formalin. Paraffin-embedded sections were cut and stained with hematoxylin and eosin for histologic examination and scoring. The DAI represents the sum of 2 scores: the clinical assessment score (CAS) and the histopathologic score (HPS). The CAS score is determined on a scale from 0 to 4 according to the occurrence of bristled fur, hunched posture, reduced activity, change in stool consistency, and rectal prolapse. The HPS is determined by scoring the most affected area of the proximal colon on a scale of 0 to 4 according to the degree of inflammatory cell infiltration, goblet cell depletion, reactive mucosal epithelial hyperplasia, and thickness of the colon wall. Histopathology grading was performed in a blinded fashion by R.W.E.
Vascularized heart rejection model
C57BL/6J, polyI/C-treated MxCreSHIP flox/flox and SHIP flox/flox mice received hearts from adult BALB/c donors. Fourteen days after the initiation of SHIP deletion, we performed vascularized heart transplantations following the procedure of Corry et al. 29 Monitoring of transplant function is assessed by daily palpation of the graft. Moderate rejection is detected by a sclerotic graft, final rejection by missing heartbeats.
Statistics
In vitro experiments are representative of at least 3 independent analyses. MLR, flow cytometry results, weight change, and HPS results were analyzed with the 2-tailed Student t test using Prism 4 software (GraphPad Software, San Diego, CA). Differences were considered significant at P values less than .05. Comparisons of graft or mouse survival were done using the Kaplan-Meier log-rank test (Prism 4 software).
Results
Mice with germline SHIP deficiency have increased numbers of conventional regulatory T cells
The expansion of T regs in SHIP-deficient mice would be consistent with the relative resistance of these mice to GVHD. 6, 7 Thus, we examined the T reg compartment in the peripheral lymphoid organs of mice from 2 different genetic models of SHIP deficiency ( Figure 1 ). Both models are germline SHIPdeficient, one having the promoter and first exon of SHIP deleted (SHIP Ϫ/Ϫ ) and the other having the exon encoding the enzymatic domain of SHIP deleted (SHIP ⌬IP/⌬IP ). Consistent with our hypothesis, we observed a significantly increased frequency and absolute number of CD25 ϩ FoxP3 ϩ T regs in the spleen and LN of both SHIP-deficient strains relative to their WT littermates ( Figure 1A ,B). In neither mutant strain is the frequency of total CD3 ϩ T cells increased in the spleen or LN. In fact, the frequency of splenic CD3 ϩ T cells is significantly decreased in both strains, whereas LN CD3 ϩ T-cell frequency remain unchanged ( Figure S1 , available on the Blood website; see the Supplemental Materials link at the top of the online article). Interestingly, FoxP3 expression levels appear to be greater in splenic SHIP-deficient T regs compared with their WT counterparts as determined by flow cytometry and Western blot analysis of sorted splenic CD25 ϩ T regs ( Figure 1C ). Thus, germline SHIP deficiency promotes a preferential expansion and/or accumulation of conventional T regs that have increased expression of FoxP3.
We then considered whether peripheral expansion of the T reg compartment might be partly the result of increased thymic production of CD25 ϩ T regs . To examine this, we assessed the thymic content of CD25 ϩ FoxP3 ϩ T regs in both SHIP-deficient strains compared with their WT littermates. We found a significant increase in the frequency of thymic CD25 Ϫ FoxP3 ϩ and CD25 ϩ FoxP3 ϩ T regs in both SHIP-deficient models relative to their WT littermates ( Figure 1D ,E). However, because SHIP-deficient mice have smaller thymuses, the absolute numbers of these FoxP3 ϩ T regs are not significantly different from their WT littermates. Thus, increased thymic output does not account for the expanded peripheral T reg compartment. On a side note, the ratio of CD4 ϩ CD8 Ϫ , CD4 ϩ CD8 ϩ , and CD4 Ϫ CD8 ϩ T cells in the thymus of SHIPdeficient mice is not significantly different from that seen in WT mice (data not shown).
SHIP regulates T reg cell compartment size during normal adult physiology
We previously found that, when SHIP deficiency is induced in adulthood, the MySC compartment expands rather rapidly, indicating that SHIP regulates MySC numbers in peripheral lymphoid tissues in response to homeostatic signals present in adult physiology. 7 To test whether this is also the case for T regs , we examined the T-cell compartment in peripheral lymphoid organs in adult MxCre-SHIP flox/flox mice after induction of SHIP deficiency. The results obtained are strikingly similar to that observed for germline SHIP deficiency. The frequency and absolute number of CD25 ϩ FoxP3 ϩ T regs are significantly increased in both the spleen and LN of MxCreSHIP flox/flox mice with induced SHIP deficiency compared with SHIP flox/flox mice (Figure 2A,B) . Thus, SHIP deficiency induced during normal adult physiology promotes the abnormal accumulation of CD25 ϩ FoxP3 ϩ T regs in the periphery, leading to a pronounced bias in the T-cell compartment toward immunosuppressive cells.
SHIP deficiency alters the expression of key receptors in the CD4 ؉ T-cell compartment
The expression of specific receptors by T regs , such as CD103, GITR, and OX40, has been associated with their regulatory function, activation status, trafficking, and retention in specific organs. We find that the percentage of CD103 ϩ cells in CD25 Ϫ and CD25 ϩ T-cell subsets is significantly increased in the spleen and LN of SHIP ⌬IP/⌬IP mice compared with WT littermates ( Figure 3A) . Examination of GITR expression in the CD25 ϩ T reg compartment in SHIP ⌬IP/⌬IP mice shows that the surface density, as determined by mean fluorescent intensity obtained from flow cytometric analysis, is also significantly greater than that seen on WT CD25 ϩ T regs in the spleen and LN ( Figure 3B ). In addition, SHIP ⌬IP/⌬IP mice exhibit a significantly larger representation of CD25 Ϫ GITR hi T cells in the spleen and LN compared with WT littermates ( Figure 3B ). Similar to GITR, in SHIP ⌬IP/⌬IP mice, there is an increased surface density of OX40 on CD25 ϩ T regs ( Figure 3C ). In addition, the frequency of OX40 ϩ cells among CD25 Ϫ T cells is significantly higher in the spleen and LN of SHIP ⌬IP/⌬IP mice compared with WT littermates ( Figure 3C ).
Recent studies attempting to define surface markers that improve purification of viable T regs showed that T regs express lower levels of the IL-7 receptor ␣ chain, CD127, than do activated effector T cells. 30 Although IL-7R signaling, like IL-2R and IL-15R signaling, is required for T reg development. In SHIP ⌬IP/⌬IP mice, we observed that CD25 ϩ T regs in spleen and LN express higher levels of CD127 (ϳ 2-fold higher mean fluorescent intensity value) compared with WT littermates ( Figure 3D ).
Furthermore, we examined the expression levels of these markers (CD103, GITR, OX40, and IL7R) among CD4 ϩ CD8 Ϫ CD25 Ϫ and CD4 ϩ CD8 Ϫ CD25 ϩ T cells in the thymus. We found no significant difference comparing SHIP ⌬IP/⌬IP thymocytes to WT thymocytes (data not shown), suggesting that the increased expression of these markers is acquired in the periphery.
As seen in other cell lineages, such as NK cells, receptors that recruit SHIP and whose activity is regulated by SHIP are often deregulated in SHIP-deficient T cells. For example, SHIP is recruited to Ly49B, a receptor found primarily on myeloid cells but not on NK cells in a WT mouse. In contrast, SHIP-deficient NK cells express Ly49B at high levels (K.H.T.P., C. Brooks, and W.G.K., unpublished data, November 28, 2006). Similarly, T cells are thought to not express Fc␥ receptors, such as Fc␥RIIb and Fc␥RIIIa, which are also regulated by SHIP and are expressed by most other hematopoietic cells. 31 When examining the expression levels of Fc␥RIIb (CD32b) and Fc␥RIIIa (CD16c) by flow cytometry using an antibody that recognizes both, we find that WT CD25 Ϫ T cells and CD25 ϩ T regs express these Fc␥Rs at low levels compared with appropriate isotype controls ( Figure 3E ). Interestingly, in spleen and LN of SHIP-deficient mice, we observed that both CD25 Ϫ T cells and CD25 ϩ T regs express significantly elevated levels of Fc␥RIIb/Fc␥RIIIa compared with WT controls. The altered phenotype described herein suggests that SHIP ⌬IP/⌬IP T regs may be more suppressive than WT T regs . To test this hypothesis in vitro, we directly compared the suppressive capacity of conventional SHIP-deficient and WT CD25 ϩ T regs at different ratios. Multiple comparisons indicate SHIP-deficient T regs are equally potent at suppressing an MLR compared with WT T regs on a per-cell basis ( Figure 4D ). To confirm that SHIP-deficient T regs are as suppressive as WT T regs , we used the in vivo syngeneic colitis model, which assesses the ability of T regs to control autoreactive T cells. We found that SHIP Ϫ/Ϫ CD25 ϩ T regs can protect C57BL/6J SCID hosts from WT CD25 Ϫ T cell-induced colitis just as well as WT CD25 ϩ T regs , as assessed by weight change and colon histopathology ( Figure 5 ). Weight change analysis showed hosts receiving either WT or SHIP Ϫ/Ϫ T regs, along with the WT effector CD25 Ϫ T cells, gained approximately 35% more of their initial weight by the end of the study, similar to the control group that received PBS only ( Figure 5A ). Hosts receiving WT effector CD25 Ϫ T cells gained approximately 10% of their initial weight, significantly less than the hosts receiving PBS or SHIP Ϫ/Ϫ or WT T regs . Comparison of the colon histopathology for hosts in each cohort further supports that those hosts receiving either SHIP Ϫ/Ϫ or WT T regs were equally protected from colitis ( Figure 5B ). The appearance and health of the colon in these hosts were very similar to that observed for hosts injected with PBS ( Figure 5C ). The colon histopathology of hosts injected with WT effector CD25 Ϫ T cells only was the most severe compared with the hosts of the other cohorts ( Figure 5B,C) . Thus, SHIP Ϫ/Ϫ Tregs appear to have comparable regulatory capacity to their WT counterparts.
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Evidence for enhanced T lymphoid immunoregulation of allogeneic responses in vivo
SHIP-deficient CD25 Ϫ T cells exhibit reduced allogeneic T-cell responses in vitro and approximately 15% of them express FoxP3 (Figure 4) . Thus, we assessed their capacity to mediate allogeneic responses in an in vivo model of GVHD-induced colitis using MHC-mismatched (H2d) Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ hosts. 27 As expected, WT CD25 Ϫ T cells mediate robust colitis and lethal GVHD in MHCmismatched hosts, resulting in only 30% survival, whereas 70% of Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ hosts survived that received an equivalent number of SHIP-deficient CD25 Ϫ T cells. This indicates that SHIPdeficient CD25 Ϫ T cells have significantly less capacity for lethal GVHD ( Figure 6A ), consistent with their reduced response in the one-way MLR assay (Figure 4) . Mice receiving SHIP-deficient CD25 Ϫ T cells also have less evidence of colitis based on both the assessment of clinical symptoms (CAS) and histopathology (HPS) For personal use only. on April 4, 2017. by guest www.bloodjournal.org From in the colon summarized in the DAI ( Figure 6C) . Specifically, the severity of colitis was approximately 2-fold less in mice receiving SHIP-deficient CD4 ϩ T cells (average DAI, 2.5) than mice that received WT CD4 ϩ T cells (average DAI, 4.6). Thus, SHIP deficiency reduces allogeneic CD4 ϩ T-cell responses that can mediate colitis, GVHD, BM graft rejection, and organ graft rejection.
To further assess immunoregulatory T-cell function in vivo in SHIP-deficient hosts, we tested whether induction of SHIP deficiency in adults could delay or prevent rejection of allogeneic organ grafts, a known function of T reg cells. We induced SHIP deficiency in MxCreSHIP flox/flox recipients by polyI/C injection. Fourteen days after the first polyI/C injection, vascularized heart grafts from BALB/C donors were placed in MxCreSHIP flox/flox and SHIP ϩ/ϩ C57BL/6J cohorts that received the same polyI/C regimen and unmanipulated SHIP flox/flox controls ( Figure 7A ). As expected with such cardiac allografts, 29 the SHIP flox/flox and C57BL/6J control cohorts both rejected the BALB/C grafts within 7 days ( Figure 7B ). However, most MxCreSHIP flox/flox recipients demonstrated a significant delay in rejection, specifically within 9 days (P Ͻ .01; Figure 7B ). These findings suggest that SHIP deficiency induced in the adult transplantation host can delay allogeneic organ graft rejection consistent with the expanded number and function of immunoregulatory T cells in SHIP-deficient hosts.
Discussion
Here we provide evidence that germline or induced systemic SHIP deficiency promotes an increased frequency of CD25 ϩ FoxP3 ϩ WT effector CD25 Ϫ T cells at the indicated ratios (suppressors/effectors) in a one-way MLR where irradiated BALB/C splenocytes were used as stimulators. This is representative of 3 independent MLR assays conducted at the indicated cell ratios. *P Ͻ .05. **P Ͻ .01. ***P Ͻ .001.
T cells and CD25 Ϫ FoxP3 ϩ T regs in secondary lymphoid tissues. Furthermore, we find that SHIP deficiency promotes a significant increased expression or representation of CD103, GITR, and OX40, markers associated with T regs , and Fc␥RII/III among CD25 ϩ T regs and CD25 Ϫ T cells. SHIP deficiency does not compromise T reg function because SHIP-deficient T regs are as suppressive as WT T regs . Finally, SHIP-deficient CD25 Ϫ T cells are unresponsive to allogeneic stimulus in vitro and in vivo and suppress allogeneic T-cell responses in vitro. Because FoxP3 expression in murine T cells confers suppressive capacity, 17 it is probable that the FoxP3 ϩ subset among SHIP-deficient CD25 Ϫ T cells is responsible for the observed immunosuppressive capacity of SHIP-deficient CD25 Ϫ T cells in vitro and reduced GVHD in vivo.
The increased representation of FoxP3 ϩ T reg populations within CD25 ϩ and CD25 Ϫ T-cell compartments could be because of several extrinsic or intrinsic effects resulting from SHIP deficiency. SHIP deficiency in T-lineage cells could alter intracellular signaling pathways important in thymic selection or peripheral differentiation or survival. Alternatively, SHIP deficiency could promote an immunosuppressive environment that preferentially promotes the generation, expansion, and/or survival of T regs . Tarasenko et al 32 found that T cell-specific SHIP deficiency does not promote the increased development or representation of FoxP3 ϩ T regs in the thymus or in peripheral lymphoid tissues. Furthermore, they showed that SHIP does not regulate signaling through the T-cell receptor. These results, when paired with our findings, suggest that SHIP deficiency promotes T reg expansion via a mechanism that is extrinsic to CD4 ϩ T cells, although the possibility exists that both a SHIP-deficient environment and a SHIP-deficient T cell are required for the increased accumulation of T regs that we observe.
Here we show that the SHIP-deficient environment promotes the expression of receptors, CD103, GITR, and OX40, which have been associated with T reg function as well as with activated T cells. Because of this, others have concluded that T cells exist in an activated state in SHIP-deficient mice. 33 The data presented in this study further characterize T cells in SHIP-deficient mice, suggesting that expression of these receptors may be representative of an activated/effector T cell that also has immunosuppressive behavior. Although T regs can suppress in an antigen nonspecific manner, T regs must undergo antigen-specific activation to suppress. 34 Thus, Figure 5 . SHIP-deficient CD4 ؉ CD25 ؉ Tregs exhibit normal immunoregulatory capacity in vivo. C57BL/6J SCID hosts received 4 ϫ 10 5 CD3 ϩ CD4 ϩ CD25 Ϫ T cells from WT C57BL/6J donors by intraperitoneal injection on day 1 (n ϭ 7). Where indicated, the WT effector CD3 ϩ CD4 ϩ CD25 Ϫ T cells were coinjected with 7 ϫ 10 4 CD3 ϩ CD4 ϩ CD25 ϩ Tregs from WT or SHIP Ϫ/Ϫ C57BL/6J donors into C57BL/6J SCID hosts (n ϭ 9). In parallel, a control group of C57BL/6J SCID hosts received a PBS injection (n ϭ 5). Disease and weight were monitored every other day. (A) Analysis of the rate of weight change over the course of the study (3 months) in the cohorts that received WT effector CD3 ϩ CD4 ϩ CD25 Ϫ T cells only (labeled WT CD25 Ϫ ), or effector WT CD3 ϩ CD4 ϩ CD25 Ϫ T cells with WT or SHIP Ϫ/Ϫ CD3 ϩ CD4 ϩ CD25 ϩ Tregs (labeled WT CD25 Ϫ and WT CD25 ϩ or WT CD25 Ϫ and Ϫ/Ϫ CD25 ϩ , respectively), or PBS. The weight change depicted was determined by converting each actual weight to a percentage of that mouse's initial weight. Each line depicts the average weight change for the specified cohort (P Ͻ .001, WT CD25 Ϫ vs WT CD25 Ϫ and WT CD25 ϩ , WT CD25 Ϫ vs WT CD25 Ϫ and SHIP Ϫ/Ϫ CD25 ϩ , and for WT CD25 Ϫ vs PBS; P Ͼ .1 for WT CD25 Ϫ and WT CD25 ϩ vs WT CD25 Ϫ and SHIP Ϫ/Ϫ CD25 ϩ , WT CD25 Ϫ and WT CD25 ϩ vs PBS, and for WT CD25 Ϫ and SHIP Ϫ/Ϫ CD25 ϩ vs PBS). (B) Histologic appearance of the colon (hematoxylin and eosin, ϫ200) from a mouse in the WT CD25 Ϫ (top left; HPS ϭ 3), WT CD25 Ϫ and WT CD25 ϩ (top right; HPS ϭ 1), WT CD25 Ϫ and Ϫ/Ϫ CD25 ϩ (bottom right; HPS ϭ 1), and PBS (bottom left; HPS ϭ 0) cohorts. Histology micrographs were taken using a Leica DMLB microscrope (N PLAN 20ϫ/0.40, total magnification ϫ200, at room temperature), and a SPOT Insight QE Model 42 camera with Spot Advanced acquisition software (Diagnostic Instruments, Sterling Heights, MI). (C) Box and whisker plots and table summarizing the histopathology scores (HPS) given to the hosts within each cohort. The HPS was determined by grading the histologic appearance of the colon using the following criteria: grade 0 indicates unaffected proximal colon; grade 1, mild leukocyte infiltration of the lamina propria (not shown); grade 2, moderate leukocyte infiltration of the lamina propria, mild reduction of goblet cells, and mild crypt epithelial regenerative hyperplasia; grade 3, marked leukocyte infiltration beyond the muscularis mucosa into a thickened submucosa, goblet cell depletion, and epithelial regenerative hyperplasia with atypia; grade 4, marked transmural leukocyte infiltration deep into a thickened submucosa and tunica muscularis with increased vascular density, marked goblet cell loss, and epithelial regenerative hyperplasia with atypia used to determine histopathologic score (HPS). P Ͻ .001, WT CD25 Ϫ versus WT CD25 Ϫ and WT CD25 ϩ , WT CD25 Ϫ versus WT CD25 Ϫ and SHIP Ϫ/Ϫ CD25 ϩ , and for WT CD25 Ϫ versus PBS; P Ͼ .5 for WT CD25 Ϫ and WT CD25 ϩ versus WT CD25 Ϫ and SHIP Ϫ/Ϫ CD25 ϩ .
BLOOD, 26 MARCH 2009 ⅐ VOLUME 113, NUMBER 13 For personal use only. on April 4, 2017. by guest www.bloodjournal.org From SHIP-deficient T regs in both CD25 ϩ and CD25 Ϫ compartments may have an increased probability of suppressing other T cells because they exist in larger numbers and a larger proportion of them exist in an activated state. Although we found that SHIP-deficient T regs are as equally potent at suppressing effector CD4 ϩ T cells as are WT T regs , SHIP-deficient T regs may still have more potent suppressive activity when in a SHIP-deficient environment. In addition, as done by Lehmann et al, 18 one can titrate the number of T regs coinjected along with WT effector CD25 Ϫ T cells to compare the smallest ratio of either SHIP-deficient or WT T regs to effector T cells at which protection from colitis is compromised or lost. Regardless, we show that SHIP-deficient Tregs are at least as suppressive as WT Tregs as assayed in vitro and in vivo.
In WT mice, GITR expression in the CD25 Ϫ and CD25 ϩ T-cell compartments represents immunoregulatory T cells capable of preventing autoimmune myocarditis, multiorgan inflammation, and murine inflammatory bowel disease. 24 These studies propose that GITR expression may be a better T reg surface marker than CD25. Similarly, in WT mice, CD25 Ϫ and CD25 ϩ T cells that express CD103 also represent a T reg subset capable of protecting mice from colitis in the SCID model in vivo. 18 Coincidentally, most GITR ϩ and CD103 ϩ T cells within CD25 ϩ and CD25 Ϫ CD4 ϩ T-cell compartments in SHIP-deficient mice also coexpress FoxP3. When using GITR or CD103 in addition to FoxP3, instead of CD25 and FoxP3, as the markers to determine the frequency of T regs , there is a more pronounced increase in the representation of CD4 ϩ GITR ϩ FoxP3 ϩ T regs or CD4 ϩ CD103 ϩ FoxP3 ϩ T regs than of CD4 ϩ CD25 ϩ FoxP3 ϩ T regs in the peripheral lymphoid organs of SHIP-deficient mice compared with that in WT mice.
As mentioned, both GITR and CD103 expression identifies a regulatory T-cell subset within the CD25 Ϫ T-cell compartment, although OX40 has not been shown to do so. Streeter et al demonstrated that CD4 ϩ CD25 Ϫ OX40 ϩ T cells are proliferative on alloantigen stimulation whereas CD4 ϩ CD25 ϩ OX40 ϩ T cells are suppressive. 35 In SHIP-deficient mice, even though there is approximately a 6-fold increase in the representation of CD25 Ϫ OX40 ϩ T cells compared with WT littermates, the SHIP-deficient CD25 Ϫ T-cell compartment as a whole was not more proliferative on alloantigen stimulation as demonstrated in vitro and in vivo. Indeed, almost half of the CD25 Ϫ OX40 ϩ T cells in SHIP-deficient mice are also FoxP3 ϩ , whereas only approximately one-fourth of WT CD25 Ϫ OX40 ϩ T cells are FoxP3 ϩ . Thus, in SHIP-deficient mice, the expression of OX40 among CD25 Ϫ T cells is more closely associated with T cells with immunoregulatory capacity instead of T cells capable of alloantigen-induced proliferation.
Engagement of costimulatory and cytokine receptors, such as OX40, GITR, CD103, IL-2R, and IL-7R, has been shown to confer survival and proliferative signals. 21, [36] [37] [38] The increased density and expression levels of these markers on CD25 Ϫ and CD25 ϩ T regs in SHIP-deficient mice may thus provide a survival advantage. SHIP is known to oppose the activation of the PI3K pathway that can be activated by IL-2R, IL-7R, or OX40 signaling. 36, 39 Indeed, inhibition of PI3K signaling prevents IL-2 and other common gamma chain cytokines, IL-7 and IL-15, from supporting maximal suppression by T regs . 39 Thus, the survival and proliferative signals emanating from these receptors may be stronger when SHIP is not present to oppose PI3K. The possibility of enhanced signaling from these receptors in combination with their increased surface expression could contribute to the increased representation of T regs in peripheral lymphoid organs of SHIP-deficient mice. These are representative examples that show grading to determine the HPS, using the criteria described in Figure 5 . Histology micrographs were taken as described in Figure 5 . (C) Table summarizing the assessment of disease in Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ mice cohorts receiving CD25 Ϫ T cells from the indicated genotype or sterile PBS control based on the clinical assessment score (CAS), the HPS and the disease activity index (DAI ϭ CAS ϩ HPS). The CAS is determined as follows: 0 indicates no signs; 1, bristled fur; 2, bristled fur with hunched posture, and/or reduced activity; 3, all of the above and change in stool consistency (eg, soft, sticky); 4, rectal prolapse. SHIP is also known to regulate signals emanating from both Fc␥RIIb, an inhibitory receptor, and Fc␥RIIIa, an activating receptor. 40, 41 Fc␥R family members recognize the immunoglobulin (Ig) Fc portion of antibodies, allowing free antibodies, immune complexes, and/or opsonized cells to fine-tune decisions between activation and suppression of an immune response. Fc␥Rs are expressed by almost all types of hematopoietic cells. Previous studies examining whether T cells express Fc␥Rs or not have been contradictory. 31 Here we show that T cells in WT mice do express low levels of Fc␥RIIb/Fc␥RIIIa. Intriguingly, SHIP-deficient CD25 Ϫ T cells and CD25 ϩ T regs express Fc␥RIIb/Fc␥RIIIa at significantly higher levels than their WT counterparts. This suggests that SHIP-deficient CD4 ϩ T cells may be responsive to antibody, immune complexes and/or opsonized cells as SHIP is known to limit signals from both of these Fc␥Rs. 40, 41 Further analysis is needed to distinguish whether unopposed signals from these Fc␥Rs occur in SHIP-deficient T cells and promote the preferable expansion of CD25 Ϫ FoxP3 ϩ T cells and CD25 ϩ FoxP3 ϩ T regs . Consistently, serum levels of certain IgG isotypes are increased in SHIP Ϫ/Ϫ mice, providing increased ligands for deregulated Fc␥Rs present on SHIP Ϫ/Ϫ CD4 ϩ T cells. 42 In addition to the increased expression of costimulatory molecules on T regs , a SHIP-deficient environment promotes other immunologic changes that promote the accumulation of T regs as well as protect against GVHD, specifically increased MySC numbers, 7, 8 and increased granulocyte colony-stimulating factor (G-CSF) expression. 43 G-CSF promotes an immunosuppressive environment and thus protects against GVHD via many mechanisms. Importantly, one study showed that in vivo G-CSF exposure promotes the acquisition of T reg properties by naive CD4 ϩ T cells after T-cell receptor ligation in vitro. 44 Consistently, donors treated with pegylated G-CSF exhibited an increased generation of IL-10-producing T regs and transplantation tolerance. 45 Furthermore, MacDonald et al showed that G-CSF and derivatives protected against GVHD by promoting the expansion of a Mac1 ϩ Gr1 ϩ subset, similar to MySC, that mediate the expansion of IL-10-secreting T regs . 11 This mechanism is plausible in a SHIP-deficient host, which is protected from GVHD, where increased G-CSF levels promote the expansion of MySC that in turn mediate expansion of the peripheral T reg compartment. Thus, SHIP may play both intrinsic and extrinsic roles to limit the accumulation of T regs .
The in vivo models described here provide further support that targeting SHIP could facilitate transplantation across MHC barriers. We show that, in addition to the MySC expansion, SHIP deficiency promotes the accumulation of T regs , which are known to play a pivotal role in transplantation immunology. 4, 46 In a model of GVHD-induced colitis, we show that isolated SHIP-deficient CD25 Ϫ T cells inefficiently mount an immune response to cause colitis. This outcome can be mediated by one of the following mechanisms. First, because SHIP-deficient CD25 Ϫ T cells could not cause colitis in a Rag2 Ϫ/Ϫ ␥c Ϫ/Ϫ mouse, which is not SHIPdeficient, SHIP may play an intrinsic role in T cells that allows robust participation in allogeneic responses. Alternatively, the SHIP-deficient environment could have led to the irreversible differentiation of some or all of the SHIP-deficient CD25 Ϫ T cells into an unresponsive and/or immunosuppressive cell. Consistently, 2 important observations can also be made from the vascularized heart transplantation model. First, a significant increase in T reg and MySC accumulation is observed in adult mice after only 8 days of induced SHIP deficiency (data not shown). Second, induced SHIP deficiency in adulthood promotes a significant delay in graft rejection. This study further characterizes the cells that make up the immunosuppressive environment promoted by SHIP deficiency, providing further support for targeting of SHIP to improve allogeneic transplantation procedures.
